BRAF and central nervous system cancer: For that purpose, we analyzed two more pediatric glioma tissues, one additional PA (ICGC_PA74, KIAA1549::BRAF fusion) and one pleomorphic xanthoastrocytoma (PXA, a CNS WHO grade 2–3 tumor, I007_024, BRAF V600E and CDK2 NA/B deletion) (Supplementary Table S2 online).